Metabolic Risk with Second-Generation Antipsychotic...

Metabolic Risk with Second-Generation Antipsychotic Treatment: A Double-Blind Randomized 8-Week Trial of Risperidone and Olanzapine

Kelly, Deanna L., Conley, Robert R., Love, Raymond C., Morrison, John A., Mcmahon, Robert P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Language:
english
Journal:
Annals of Clinical Psychiatry
DOI:
10.1080/10401230802017050
Date:
May, 2008
File:
PDF, 125 KB
english, 2008
Conversion to is in progress
Conversion to is failed